# ETHAN - ET for Male BC

> **NCT05501704** · PHASE2 · RECRUITING · sponsor: **Jose Pablo Leone** · enrollment: 60 (estimated)

## Conditions studied

- Male Breast Cancer
- Hormone Receptor-positive Breast Cancer
- Hormone Receptor Negative Breast Carcinoma

## Interventions

- **DRUG:** Tamoxifen
- **DRUG:** Anastrozole
- **DRUG:** Degarelix
- **DRUG:** Abemaciclib

## Key facts

- **NCT ID:** NCT05501704
- **Lead sponsor:** Jose Pablo Leone
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-11
- **Primary completion:** 2027-04-01
- **Final completion:** 2036-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05501704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05501704, "ETHAN - ET for Male BC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05501704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*